Dialysis
Baxter blows away Wall Street as renal sales surge in Q1
Fresenius’ renal research division gets a makeover
Nephros expands European distribution deal
Nephros (OTC:NEPH) said it plans to extend and expand its deal with Italian distributor Bellco Srl, adding more countries to their existing deal.
Mirandola-based Bellco is focused on providing dialysis and extracorporeal blood purification technology. The 2 companies have extended their deal until Dec. 31, 2021, according to a press release.
NxStage Medical tops Q4, 2013 estimates
NxStage Medical (NSDQ:NXTM) shares rose today after the medical device company said it just beat estimates with its results for the 4th quarter and last year.
Gore’s Viabahn stent graft bests angioplasty, study finds
Arizona medical device maker W.L. Gore & Assoc. teased positive results from its REVISE clinical trial, promising to release additional findings during the American Society of Diagnostic & Interventional Nephrology meeting in Phoenix this week.
NxStage launches dialysis patient outreach program
NxStage Medical (NSDQ:NXTM) launched a new patient outreach program called NxStage Plus One, through which it hopes to increase awareness of home hemodialysis with the NxStage System One.
Baxter beats The Street with Q4 numbers, but Gambro buy pushes profits down
NxStage Medical’s Q4 prelims beat its own, Wall Street’s forecasts
NxStage Medical (NSDQ:NXTM) saw its stock price climb this morning after reporting preliminary 4th-quarter sales numbers that topped its own forecast and handily beat expectations on Wall Street.
NxStage, Fresenius extend System One deal
Fresenius (NYSE:FMS) and NxStage Medical (NSDQ:NXTM) said they extended a supply deal for NxStage’s System One hemodialysis device until 2016.